Globus Medical, Inc.(GMED) Stock Research - Grey Stern Research

Globus Medical, Inc. (GMED) Stock Analysis

$72.96 (0.22%)

GMED Financial Performance


Use the table below to view Globus Medical, Inc.'s financial profile. This data is gathers from the latest available financial statements. Annual data is taken from the trailing 12 months of statements. All numbers are reported in US Dollars and so any foreign currencies are converted to USD so comparison's can be done.

Based on Financial Statements from Q4 - 2024

Metric Value Ranking among Peers
Price $72.80 -
52 Week Low $49.33 -
52 Week High $94.93 -
Market Cap $11.6 Billion 2/16
Gross Margin 60% 12/16
Profit Margin 4% 6/16
EBITDA margin 22% 3/16
Q4 - 2024 Revenue $657.3 Million 2/16
Q4 - 2024 Earnings $26.5 Million 6/16
Q4 - 2024 Free Cash Flow $193.2 Million 1/16
Trailing 4 Quarters Revenue $2.5 Billion 2/16
Trailing 4 Quarters Earnings $103.0 Million 5/16
Quarterly Earnings Growth 76% 5/16
Annual Earnings Growth 471% 3/16
Quarterly Revenue Growth 7% 10/16
Annual Revenue Growth 43% 1/16
Cash On Hand $784.4 Million 2/16
Short Term Debt $20.5 Million 7/16
Long Term Debt $526.9 Million 7/16

Globus Medical, Inc. Financial Metrics


Financial metrics are a set of useful numbers that can give key performance indicators of a company. The various metrics can include information about profitability, growth, and debt load. When combined and use properly they can tell an analyst a compelling fact-based story of how the company is currently performing. To compare Globus Medical, Inc.'s metrics versus it's peers make sure to run our peer analysis tool.

Valuation Metrics

Metric Value Ranking among Peers
PE 113.08 1/16
PS 4.62 7/16
PB 2.79 10/16
PC 14.85 9/16
Liabilities to Equity 0.26 15/16
ROA 0.02 6/16
ROE 0.02 8/16
Current Ratio 4.89 2/16
Quick Ratio 0.83 5/16
Long Term Debt to Equity 0.13 11/16
Debt to Equity 0.13 11/16
Burn Rate -2589.42 16/16
Cash to Cap 0.07 8/16
CCR 7.29 2/16
EV to EBITDA 78.46 5/16
EV to Revenue 4.52 7/16

Company Details

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

CEO: Mr. David Demski

Website: https://www.globusmedical.com

Address: 2560 General Armistead Ave Audubon, PENNSYLVANIA

Exchange: New York Stock Exchange

Industry: Medical Devices

Globus Medical, Inc. Peer Analysis


A useful and more reliable way of seeing the health of a company is to compare it to other companies operating in the same sector. Below is our list of companies which we rank are the closest peers to Globus Medical, Inc.. If you feel that peers should be added or removed from this list please contact us. To run an in-depth peer analysis which compares many financial metrics click on the link below.

Stock Ticker Market Cap
Glaukos Corporation GKOS $5.5 Billion
LivaNova PLC LIVN $2.0 Billion
Insulet Corporation PODD $18.3 Billion
Bruker Corporation BRKR $5.9 Billion
NuVasive, Inc. NUVA $2.1 Billion
NovoCure Limited NVCR $2.1 Billion
Nevro Corp. NVRO $224.1 Million
iRhythm Technologies, Inc. IRTC $3.4 Billion
Integer Holdings Corporation ITGR $4.3 Billion
CONMED Corporation CNMD $1.6 Billion
Heska Corporation HSKA $1.3 Billion
Orthofix Medical Inc. OFIX $553.7 Million
Alphatec Holdings, Inc. ATEC $1.5 Billion
Inspire Medical Systems, Inc. INSP $4.7 Billion
Inari Medical, Inc. NARI $4.7 Billion
Run Peer Analysis
Income Statement
Balance Sheet
Cash Flow Statement
GMED Income Statements
Quarter Year Revenue Earnings
Q4 2024 $ 657.3 Million $26.5 Million
Q3 2024 $ 625.7 Million $51.8 Million
Q2 2024 $ 629.7 Million $31.8 Million
Q1 2024 $ 606.7 Million -$7.1 Million
Q4 2023 $ 616.5 Million $15.0 Million
Q3 2023 $ 383.6 Million $998,000
Q2 2023 $ 291.6 Million $57.7 Million
Q1 2023 $ 276.7 Million $49.1 Million

View All

GMED Balance Sheets
Quarter Year Cash & Equivalents Total Assets Total Debt Total Equity
Q4 2024 $784.4 Million $5.3 Billion $537.2 Million $4.2 Billion
Q3 2024 $622.8 Million $5.1 Billion $534.6 Million $4.1 Billion
Q2 2024 $410.4 Million $5.0 Billion $531.0 Million $4.0 Billion
Q1 2024 $354.1 Million $4.9 Billion $526.3 Million $3.9 Billion
Q4 2023 $467.3 Million $5.1 Billion $520.4 Million $4.0 Billion
Q3 2023 $279.6 Million $5.4 Billion $523.0 Million $4.2 Billion
Q2 2023 $306.5 Million $2.2 Billion $0 $2.0 Billion
Q1 2023 $217.7 Million $2.1 Billion $0 $1.9 Billion

View All

GMED Cash Flow Statements
Quarter Year freeCashFlow capitalExpenditure netChangeInCash
Q4 2024 $193.2 Million -$17.1 Million $161.7 Million
Q3 2024 $161.7 Million -$42.0 Million $212.3 Million
Q2 2024 $26.5 Million -$27.8 Million $56.4 Million
Q1 2024 $23.8 Million -$28.6 Million -$113.2 Million
Q4 2023 $81.8 Million -$22.9 Million $187.7 Million
Q3 2023 $0 $0 $1.2 Million
Q2 2023 $17.2 Million -$17.9 Million $88.8 Million
Q1 2023 $37.3 Million -$16.0 Million $67.2 Million

View All

Cookies

We use cookies to offer a better browsing experience. Cookies enhance site navigation, analyze site usage, and assist in our marketing efforts. By clicking Accept. you agree to the storing of cookies on your device. To refuse all non-required cookies, click on Decline.

Accept View Terms & Conditions